Table II.

Magnitude of peptide-specific CD8+ T cell responses directed against Vpr overlapping peptides as measured by IFN-γ ELISPOT (SFC/106 PBMC) in persons with treated acute (AC), treated chronic (C), and untreated long-term nonprogressive infection (L)

Vpr-2Vpr-3Vpr-4Vpr-6Vpr-7Vpr-9Vpr-10Vpr-11Vpr-12Vpr-13
AC-04000000004500
AC-06000022000000
AC-092802600000003100
AC-10000006000000
AC-1300013000002200
AC-27000310000000
AC-310000000000
AC-38000021000000
AC-4300080000000
AC-46000000008500
AC-49000011000000
AC-5580000000000
AC-59000038000000
AC-60000001300120003600
AC-63000015000000
AC-TZA000260000000
C-JRH0000000014000
C-600200000000500
C-600500000000700
C-600300060000000
C-600900000400000
C-6010000000013000
L-CMW00000400000
L-MJR000017037001801800
L-TMH#4003402502402200000
L-TMH#6000000002500
L-CWE00000000540380